Clinical experience with sotalol in patients with drug-refractory ventricular Arrhythmias

This publication has 31 references indexed in Scilit:

• Sotalol in patients with Wolff-Parkinson-White syndrome.
  Circulation, 1987
• Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: Evaluation by programmed stimulation and ambulatory electrocardiogram
  Journal of the American College of Cardiology, 1986
• Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
  Circulation, 1986
• Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
  Circulation, 1985
• Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.
  Circulation, 1984
• Prolongation of the human cardiac monophasic action potential by sotalol
  The American Journal of Cardiology, 1982
• Electrophysiological effects of sotalol--just another beta blocker?
  Heart, 1982
• Effect of sotalol on clinical arrhythmias
  The American Journal of Cardiology, 1972
• A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474
  British Journal of Pharmacology, 1970
• Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue
  Circulation Research, 1970